Optimizing human in vivo dosing and delivery of β-alanine supplements for muscle carnosine synthesis.

The research article discusses how prolonged β-alanine (BA) supplementation can significantly increase muscle carnosine concentrations, and explores the optimization of BA supplements dosage for muscle carnosine synthesis.

Introduction and Background

• The research focuses on carnosine, a compound that has attracted growing interest due to its potential effects on cellular metabolism.
• Prior to this study, it was already established that β-alanine (BA) supplements can increase muscle carnosine concentrations by over 50% when taken consistently (3-6 g BA/day for roughly 4 weeks).
• The potential applications of BA supplements are not limited to exercise and performance enhancement but also extend to other clinical areas.

Previous Studies and their Findings

• The research critically reviewed previous studies that were centered on BA supplementation and their direct impact on muscle carnosine levels.
• There was a significant linear correlation found between the total amount of BA consumed (daily dosage range of 1.6-6.4 g BA/day) and the relative and absolute increases in muscle carnosine.
• An earlier dose-response study showed a substantial linear dependence based on total grams of BA consumed over 8 weeks.
• The pre-supplementation baseline carnosine or the individual’s body weight did not seem to affect muscle carnosine synthesis from BA consumption.
• A slow-release BA tablet was developed, which showed a smaller peak plasma BA concentration and delayed time to peak. Still, there was no difference in the area under the curve compared to pure BA in solution.

Observations and Findings

• The research found that once muscle carnosine was boosted, the washout time was greatly prolonged (approximately 2% per week). This indicates that augmentation of muscle carnosine through BA supplementation can sustain elevated muscle carnosine concentrations for a long time.
• The researchers also found that usage of a slow-release BA tablet resulted in reduced urinary excretion of BA and improved retention. It also created minimal paraesthesia symptoms in comparison to pure BA in solution.

Conclusion and Future Work

• While the study brought forward new insights into in vivo delivery and dosing of BA for muscle carnosine synthesis, it also highlighted that the full understanding of this process is still in the early stages.
• The authors urged for more studies to be conducted to clarify current knowledge of BA supplementation to augment muscle carnosine, and also to investigate potential regulatory points of control for muscle carnosine synthesis.